Risk-adapted therapy in adults with Burkitt lymphoma: Results of NCI 9177, a multicenter prospective phase II study of DA-EPOCH-R Meeting Abstract
| Authors: | Roschewski, M.; Dunleavy, K.; Abramson, J. S.; Link, B. K.; Parekh, S.; Jagadeesh, D.; Bierman, P.; Mitsuyasu, R. T.; Battini, R.; Watson, P. R.; Peace, D.; Hanna, W.; Powell, B. L.; O'Brien, T. E.; King, D.; Melani, C.; Lucas, A.; Steinberg, S. M.; Kahl, B. S.; Friedberg, J. W.; Little, R. F.; Bartlett, N. L.; Fanale, M. A.; Noy, A.; Wilson, W. H. |
| Abstract Title: | Risk-adapted therapy in adults with Burkitt lymphoma: Results of NCI 9177, a multicenter prospective phase II study of DA-EPOCH-R |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419400243 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.188.188 |
| Notes: | Meeting Abstract: 188 -- Source: Wos |
